Immunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule. • Arctic Health

It appears no script is enabled within your browser. Please enable JavaScript to use this site.

Home

View Selections: 0 Items Help

Immunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule.

https://arctichealth.org/en/permalink/ahliterature199014

Source: Indian Pediatr. 2000 Jan;37(1):75-80

Publication Type: Article

Date: Jan-2000

Author: T S Kumar; P. Abraham; S. Raghuraman; T. Cherian

Author Affiliation: Department of Child Health, Christian Medical College and Hospital, Vellore 632 004, Tamil Nadu, India.

Source: Indian Pediatr. 2000 Jan;37(1):75-80

Date: Jan-2000

Language: English

Publication Type: Article

Keywords: Consumer Product Safety; Diphtheria-Tetanus-Pertussis Vaccine - pharmacology; Hepatitis B - immunology - prevention & control; Hepatitis B Vaccines - pharmacology - therapeutic use; Humans; Immunization Schedule; Infant; Infant, Newborn; Vaccines, Synthetic - pharmacology - therapeutic use

PubMed ID: 10745392 View in PubMed